What we do…

Knome specializes in the interpretation of human whole genomes. With knomeBASE and knomeDISCOVERY, we support academic, pharmaceutical, and biotech researchers with the informatics, services, and software they need to investigate the genetic basis of disease and drug response. With knomeCLINIC, we provide clinics with enterprise-wide genome interpretation systems for both medical research and patient care.

Latest News

11 May 2012

GATTACA: is there a gene for the human spirit?

Contributed by Elizabeth Ricker What better group to view the dystopic science fiction movie Gattaca than those attempting to discern and make real the better parts of its science?  In early spring, the Knome team crowded into our conference room … more

19 Apr 2012

Thoughts on genomes, health, and the new paper on risk prediction from twin studies

A controversial new paper from Nicholas Roberts, Bert Vogelstein, and colleagues starts with a simple and longstanding observation: so-called identical twins don’t always get the same diseases. Reviewing data from old twin studies, the authors try to use that observation … more

03 Apr 2012

Knome selected as a genome interpretation partner for Illumina Genome Network

Firms partner to offer Illumina’s high-quality genome sequencing services in combination with Knome’s advanced genome interpretation solutions CAMBRIDGE, MA – April 3, 2012 – Knome Inc., the human genome interpretation company, announced today that it has been selected by Illumina, … more

03 Apr 2012

Knome expands executive management team, positions company for growth

Appoints Charles Abdalian as CFO, Adam Rosenberg as Head of Corporate Development, and Jay Therrien as Head of Global Sales CAMBRIDGE, MA – April 3, 2012 – Knome Inc., the human genome interpretation company, today announced that it has continued … more

03 Apr 2012

Knome appoints Hugh Y. Rienhoff, Jr., MD to Scientific Advisory Board

Dr. Rienhoff brings deep industry and technical expertise as Knome continues to expand CAMBRIDGE, MA – April 3, 2012 – Knome, Inc., the human genome interpretation company, today announced that it has continued to expand its scientific advisory board to … more